Cancer

New Business

China biotech forum bills antibody cancer drugs as next-generation treatment

Antibody-drug conjugates (ADC), a fast-growing next-generation cancer treatment, have become an investment hotspot due to its potential to become mainstream…

Read More »
New Business

China’s Akeso, dubbed biotech’s DeepSeek, gets share boost on cancer-drug trial data

Shares of Chinese drug firm Akeso – likened by some Western media outlets to artificial intelligence start-up DeepSeek – rose…

Read More »
New Business

China’s healthcare sector sees record US$10.6 billion fundraising as biotech booms

China’s healthcare sector is on track to secure record fundraising this year, driven by robust global investor demand and growth…

Read More »
New Business

Chinese pharma firms Hengrui, Hansoh expected to post strong first-half profits

Jiangsu Hengrui Pharmaceuticals and Hansoh Pharmaceutical Group, two of China’s largest drug makers, are expected to report significantly improved profits,…

Read More »
New Business

Blondie drummer Clem Burke dies aged 70 after private battle with cancer

Clem Burke, the iconic drummer of Blondie, has passed away at the age of 70 following a private battle with…

Read More »
New Business

China expands health insurance coverage with 91 new drugs, breakthrough treatments

China has added dozens of new drugs to its health insurance reimbursement list, signalling support for innovative treatments while keeping…

Read More »
New Business

Li Ka-shing’s HutchMed sets up first drugs research facility in Hong Kong

HutchMed aims to establish a bigger presence in the city when the first wet laboratories at the much larger Hong…

Read More »
Tech

Yifan Pharma’s unit, eyeing US$5.5 billion post-chemotherapy treatment market dominated by Amgen, considers IPO in 2021

Evive Biotech, a unit of Shenzhen-listed Yifan Pharmaceutical, aims to break the dominance of American drugs developer Amgen in the…

Read More »
Tech

Billionaire Li Ka-shing’s biotech unit hopes for new cancer drug approvals, expands sales army in China amid stock rally in London

Hutchison China MediTech (Chi-Med), whose stock has surged 70 per cent in London over the past six months, expects to…

Read More »
Tech

UK hospitals begin live trial of prostate cancer-detecting AI

Three hospital systems across England have begun a live clinical trial of AI technology designed to detect and grade prostate…

Read More »
Back to top button